Updated:
Hobart Group
Hobart Group is a medical device company based in Hamilton, Bermuda. It develops and commercializes technologies for cardiology, diabetes, oncology, neurology,...
Hobart Group
Hobart Group is a medical device company based in Hamilton, Bermuda. It develops and commercializes technologies for cardiology, diabetes, oncology, neurology, and rehabilitation.
General information
Firm type
Generalist
Location
Region
Europe
Country
Switzerland
City
Geneva
Corporate office
Geneva, Switzerland
Principals
Shlomo Ben-Haim
Founder
Amit Ben-Haim
Family Member
Sector focus
Frequently asked questions
Who runs investment decisions at Hobart Group?
Investment decisions are led by founder Shlomo Ben-Haim, a professor of medicine, physics, and biophysics with a track record as a serial entrepreneur in medical technology. His brother Amit Ben-Haim also plays a role as a family member and entrepreneur.
How does Hobart Group source proprietary deal flow?
The firm leverages its founder's academic and entrepreneurial network in medical technology, along with strategic partnerships with Royal Philips and MSD Global Health Innovation Fund. Co-investment relationships provide access to deal flow in image-guided therapy and digital health.
What investment stages does Hobart Group typically target?
Hobart Group targets early-stage through growth stages, including seed and startup rounds, with a venture generalist approach. Its strategy spans pre-seed to growth equity in medical technology and digital health.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: